Lv3
360 积分 2026-01-29 加入
Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane
20小时前
已关闭
Vonoprazan improves the efficacy of bismuth quadruple therapy containing doxycycline and metronidazole as first-line Helicobacter pylori treatment in penicillin-allergic patients: a randomized controlled trial
17天前
已完结
Rifabutin triple therapy increased H pylori eradication vs. amoxicillin + omeprazole in treatment-naive patients
17天前
已完结
High-Dose Dual Therapy versus Triple Therapy for Treatment of H. Pylori Infection: A Parallel Randomized Study
17天前
已关闭
The high-dose dual therapy for eradication of <i>Helicobacter pylori</i>: efficacy and safety
17天前
已关闭
Vonoprazan With Amoxicillin or Amoxicillin and Clarithromycin for the Treatment of Helicobacter pylori Infection
17天前
已完结
Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication
17天前
已完结
Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled study
17天前
已完结
Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori
18天前
已完结
皖公网安备34019202002308
